Please see below for a list of search results.
Although NHSBT keeps a register of all living donors for follow-up, all transplant centres are required to keep this information on site. Local practice will vary depending on how follow-up clinical visits, or visits to local GPs or hospitals are managed.
The HTA directs, that for living donation, only CPA or UKAS accredited laboratories should be used, unless by doing so there is a risk to the donor or recipient which would outweigh the risk of using a non-accredited laboratory or one with an unknown status, e.g. due to time constraints in an...
In the context of testing, examples of SAEs may be related to mislabelling, transcription errors, loss of traceability of samples, failure in testing protocols etc. All incidents should be reported to NHSBT. NHSBT will then report incidents falling into the category of SAEARs to the HTA.
It is a statutory condition of an ODT licence to report SAEARs to NHSBT on behalf of the HTA within 24 hours of discovery of the incident by the licence holder. Establishments should have in place operating procedures for the management of a serious adverse event or a serious adverse reaction...
A serious adverse event (SAE) is defined in the Regulations as ‘any undesired and unexpected occurrence associated with any stage of the chain from donation to transplantation that might lead to the transmission of a communicable disease, to death or life-threatening, disabling or incapacitating...
Yes. There must be consent for research in place from the donor or a person in a qualifying relationship to the donor immediately before their death.
A comprehensive suite of National Operating Procedures (NOPs) are available on the NHSBT microsite. There are NOPs covering:
The EUODD does not specify how frequently audits should occur. The EUODD requires that ‘procurement organisations and transplantations centres are controlled or audited on a regular basis’.